DNA methylation analysis of aortic wall tissue in ascending aortic dilatation/aneurysm and dissection.
- 1Research Institute of Medical Genetics, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.
Abstract
Ascending aortic dilatation/aneurysm and dissection are life-threatening cardiovascular conditions. However, the epigenetic regulatory mechanisms within aortic cells underlying these pathologies remain poorly understood. This study aimed to identify differentially methylated genes (DMGs) in aortic tissues from patients with ascending aortic dilatation/aneurysm and dissection by performing a re-analysis of publicly available DNA methylation datasets. A re-analysis was conducted on three DNA methylation datasets (GSE50192, GSE202047, GSE84274) from the Illumina Infinium HumanMethylation450 BeadChip. To account for tissue heterogeneity, cellular deconvolution was performed using the HEpiDISH algorithm and a custom reference panel of cell-type-specific CpG sites for key vascular cell types (endothelial cells, fibroblasts, smooth muscle cells, immune cells). Our re-analysis revealed that aortic dissection and bicuspid aortic valve patients with aortic dilatation/aneurysm exhibit distinct DNA methylation profiles compared to intact aorta. These pathologies differ from each other in the number and the spectrum of DMGs. The adjustment for cellular heterogeneity eliminated the majority of the initially identified DMGs. However, this correction helped to make an assessment of vascular inflammation, characterize its impact on aortic wall stability, and identify genes with differential DNA methylation associated with the disease phenotypes, rather than with inter-group heterogeneity. The genes NFIX, PCDH7, MED13L, LMO4, DIP2C, PLEKHF1, NKD1, C10orf41 (ZNF503-AS2), ARAP2, TBX3, and TBX5, which remained in the DMG status after adjustment for cellular composition and are expressed in individual cells/whole aortic tissue, can be considered as new candidate genes for the development of aortic dilatation/aneurysm in patients with bicuspid aortic valve. NFIX, LMO4, DIP2C, C10orf41 (ZNF503- AS2), MED13L, TBX3, TBX5 are transcriptional regulators or modulators; NKD1 is a recognized inhibitor of the Wnt pathway. Our findings highlight the necessity of a rigorous approach to cohort design, which includes comprehensive phenotyping (encompassing aortic valve morphology) and underscore the importance of future single-cell investigations.
Related
- Associations of age, sex, and bicuspid aortic valve with biaxial mechanical properties and circumferential residual stress in ascending thoracic aortic aneurysm
- Double Mutations in the FLNA and MYH11 Genes Causing Familial Thoracic Aortic Aneurysm and Dissection: A Report of Two Cases
- Probable Loeys-Dietz Syndrome with aortic root dilatation and multiple arterial tortuosity in resource-limited setting : A case report.
- Spatial multi-omics reveals novel vascular adipocyte and B cell biology in human abdominal aortic aneurysm
- Maternal E-cigarette Exposure Augments Murine Abdominal Aortic Aneurysm
BibTeX
@article{goncharova2026methylation,
title = {{DNA methylation analysis of aortic wall tissue in ascending aortic dilatation/aneurysm and dissection.}},
author = {I A Goncharova and A A Zarubin and A V Markov and S A Shipulina and N P Babushkina and Iu A Koroleva and A A Sleptcov and M S Nazarenko},
journal = {Vavilovskii zhurnal genetiki i selektsii},
year = {2026},
month = oct,
doi = {10.18699/vjgb-26-94},
url = {https://europepmc.org/article/MED/42908883},
note = {CC BY},
}
RIS
TY - JOUR
TI - DNA methylation analysis of aortic wall tissue in ascending aortic dilatation/aneurysm and dissection.
AU - I A Goncharova
AU - A A Zarubin
AU - A V Markov
AU - S A Shipulina
AU - N P Babushkina
AU - Iu A Koroleva
AU - A A Sleptcov
AU - M S Nazarenko
PY - 2026
DA - 2026/10/01
JO - Vavilovskii zhurnal genetiki i selektsii
DO - 10.18699/vjgb-26-94
UR - https://europepmc.org/article/MED/42908883
AB - Ascending aortic dilatation/aneurysm and dissection are life-threatening cardiovascular conditions. However, the epigenetic regulatory mechanisms within aortic cells underlying these pathologies remain poorly understood. This study aimed to identify differentially methylated genes (DMGs) in aortic tissues from patients with ascending aortic dilatation/aneurysm and dissection by performing a re-analysis of publicly available DNA methylation datasets. A re-analysis was conducted on three DNA methylation datasets (GSE50192, GSE202047, GSE84274) from the Illumina Infinium HumanMethylation450 BeadChip. To account for tissue heterogeneity, cellular deconvolution was performed using the HEpiDISH algorithm and a custom reference panel of cell-type-specific CpG sites for key vascular cell types (endothelial cells, fibroblasts, smooth muscle cells, immune cells). Our re-analysis revealed that aortic dissection and bicuspid aortic valve patients with aortic dilatation/aneurysm exhibit distinct DNA methylation profiles compared to intact aorta. These pathologies differ from each other in the number and the spectrum of DMGs. The adjustment for cellular heterogeneity eliminated the majority of the initially identified DMGs. However, this correction helped to make an assessment of vascular inflammation, characterize its impact on aortic wall stability, and identify genes with differential DNA methylation associated with the disease phenotypes, rather than with inter-group heterogeneity. The genes NFIX, PCDH7, MED13L, LMO4, DIP2C, PLEKHF1, NKD1, C10orf41 (ZNF503-AS2), ARAP2, TBX3, and TBX5, which remained in the DMG status after adjustment for cellular composition and are expressed in individual cells/whole aortic tissue, can be considered as new candidate genes for the development of aortic dilatation/aneurysm in patients with bicuspid aortic valve. NFIX, LMO4, DIP2C, C10orf41 (ZNF503- AS2), MED13L, TBX3, TBX5 are transcriptional regulators or modulators; NKD1 is a recognized inhibitor of the Wnt pathway. Our findings highlight the necessity of a rigorous approach to cohort design, which includes comprehensive phenotyping (encompassing aortic valve morphology) and underscore the importance of future single-cell investigations.
SN - 2500-0462
SN - 2500-3259
ER -